Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
25.56 USD +1.63% Intraday chart for Protagonist Therapeutics, Inc. -4.80% +11.47%
Apr. 03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT
Mar. 26 Protagonist Therapeutics, Inc. Provides Update on Verify Patient Enrollment and Timing of Top-Line Data CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Today on Wall Street: It's just a period of market normalizationToday on Wall Street: It's just a period of market normalization October 12, 2021 at 09:16 am EDT
Analyst recommendations: Cigna, Halliburton, Nike, Nio, Trex...ANALYST RECOMMENDATIONS : Cigna, Halliburton, Nike, Nio, Trex... October 12, 2021 at 06:20 am EDT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. News Protagonist Therapeutics, Inc.
  5. MarketScreener Editorial Features